Elabela, a Novel Peptide, Exerts Neuroprotective Effects Against Ischemic Stroke Through the APJ/miR-124-3p/CTDSP1/AKT Pathway

Elabela (ELA), which is the second endogenous peptide ligand of the apelin receptor (APJ) to be discovered, has been widely studied for potential use as a therapeutic peptide. However, its role in ischemic stroke (IS), which is a leading cause of disability and death worldwide and has limited therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Kang-long, Li, Shuang-mei, Hou, Jing-yu, Hong, Ying-hui, Chen, Xu-xiang, Zhou, Chang-qing, Wu, Hao, Zheng, Guang-hui, Zeng, Chao-tao, Wu, Hai-dong, Fu, Jia-ying, Wang, Tong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333378/
https://www.ncbi.nlm.nih.gov/pubmed/37106272
http://dx.doi.org/10.1007/s10571-023-01352-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333378/
https://www.ncbi.nlm.nih.gov/pubmed/37106272
http://dx.doi.org/10.1007/s10571-023-01352-6

Ejemplares similares